Detailed Information
Cited 2 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Six-year safety and efficacy results from the CHRONOS-1 study of the PI3K inhibitor copanlisib in patients with relapsed or refractory follicular lymphoma
- Authors
- Dreyling, MH[Dreyling, Martin H.]; Santoro, A[Santoro, Armando]; Leppa, S[Leppa, Sirpa]; Demeter, J[Demeter, Judit]; Follows, G[Follows, George]; Lenz, G[Lenz, Georg]; Kim, WS[Kim, Won Seog]; Mollica, L[Mollica, Luigina]; Nagler, A[Nagler, Arnon]; Diong, CP[Diong, Colin Phipps]; Provencio, M[Provencio, Mariano]; Magagnoli, M[Magagnoli, Massimo]; Radinoff, A[Radinoff, Atanas]; Munoz, J[Munoz, Javier]; Cao, AJ[Cao, Anjun]; Hiemeyer, F[Hiemeyer, Florian]; Odongo, F[Odongo, Fatuma]; Garcia-Vargas, JE[Garcia-Vargas, Jose E.]; Childs, BH[Childs, Barrett H.]; Zinzani, PL[Zinzani, Pier Luigi]
- Issue Date
- 1-Jun-2023
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.41, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 41
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.